GT199900046A - Procedimiento para la preparaciòn deacidos hidroxàmicos. - Google Patents

Procedimiento para la preparaciòn deacidos hidroxàmicos.

Info

Publication number
GT199900046A
GT199900046A GT199900046A GT199900046A GT199900046A GT 199900046 A GT199900046 A GT 199900046A GT 199900046 A GT199900046 A GT 199900046A GT 199900046 A GT199900046 A GT 199900046A GT 199900046 A GT199900046 A GT 199900046A
Authority
GT
Guatemala
Prior art keywords
procedure
preparation
hydroxamic
decides
hydroxymic
Prior art date
Application number
GT199900046A
Other languages
English (en)
Inventor
Joe Michael Hawkins
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT199900046A publication Critical patent/GT199900046A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C239/00—Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof
    • C07C239/08—Hydroxylamino compounds or their ethers or esters
    • C07C239/14—Hydroxylamino compounds or their ethers or esters having nitrogen atoms of hydroxylamino groups further bound to carbon atoms of hydrocarbon radicals substituted by doubly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/40—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Abstract

LA INVENCIÒN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACIÒN DE ÀCIDOS HIDROXÀMICOS A PARTIR DE INTERMEDIOS ÀCIDO HIDROXÌLICO, EN EL QUE EL INTERMEDIO DE ÀCIDO CARBOXÌLICO NO POSEE SUSTITUYENTES REACTIVOS, TALES COMO GRUPOS HIDROXI O AMINO.
GT199900046A 1998-04-10 1999-03-25 Procedimiento para la preparaciòn deacidos hidroxàmicos. GT199900046A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8136598P 1998-04-10 1998-04-10

Publications (1)

Publication Number Publication Date
GT199900046A true GT199900046A (es) 2000-09-15

Family

ID=22163686

Family Applications (1)

Application Number Title Priority Date Filing Date
GT199900046A GT199900046A (es) 1998-04-10 1999-03-25 Procedimiento para la preparaciòn deacidos hidroxàmicos.

Country Status (38)

Country Link
US (1) US6288246B1 (es)
EP (1) EP0949244A3 (es)
JP (1) JPH11343277A (es)
KR (1) KR100329902B1 (es)
CN (1) CN1232023A (es)
AP (1) AP1203A (es)
AR (1) AR018180A1 (es)
AU (1) AU747629B2 (es)
BG (1) BG64154B1 (es)
BR (1) BR9901089A (es)
CA (1) CA2268680A1 (es)
CO (1) CO5070713A1 (es)
DZ (1) DZ2757A1 (es)
EA (1) EA002777B1 (es)
EG (1) EG22263A (es)
GT (1) GT199900046A (es)
HR (1) HRP990105A2 (es)
HU (1) HUP9901041A3 (es)
ID (1) ID23337A (es)
IL (1) IL129328A0 (es)
IN (1) IN192342B (es)
IS (1) IS5019A (es)
MA (1) MA24831A1 (es)
NO (1) NO991672L (es)
NZ (1) NZ335104A (es)
OA (1) OA11031A (es)
PA (1) PA8469301A1 (es)
PE (1) PE20000418A1 (es)
PL (1) PL332450A1 (es)
SG (1) SG125880A1 (es)
SK (1) SK43699A3 (es)
TN (1) TNSN99052A1 (es)
TR (1) TR199900755A2 (es)
TW (1) TW448147B (es)
UA (1) UA57750C2 (es)
UY (1) UY25460A1 (es)
YU (1) YU18199A (es)
ZA (1) ZA992631B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9918684D0 (en) 1999-08-09 1999-10-13 Novartis Ag Organic compounds
US6458822B2 (en) 2000-03-13 2002-10-01 Pfizer Inc. 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
GB0103303D0 (en) 2001-02-09 2001-03-28 Novartis Ag Organic compounds
WO2004106319A1 (en) * 2003-05-30 2004-12-09 Pfizer Products Inc. Crystal forms of 4-[4-(4-fluorophenoxy)benzenesulfonylamino]-tetrahydropyran-4-carboxylic acid hydroxyamide
AU2003264355A1 (en) * 2003-08-29 2005-03-29 Basf Aktiengesellschaft Process for production of o-substituted hydroxylamines
CA2933174A1 (en) 2013-12-18 2015-06-25 Brita Lp Filter assembly for filter as you pour filtration
TW202237119A (zh) 2020-12-10 2022-10-01 美商住友製藥腫瘤公司 Ａｌｋ﹘５抑制劑和彼之用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA794723B (en) 1978-09-11 1980-08-27 Univ Miami Anti-hypertensive agents
GB9000725D0 (en) 1990-01-12 1990-03-14 Pfizer Ltd Therapeutic agents
US5552419A (en) * 1993-01-06 1996-09-03 Ciba-Geigy Corporation Arylsulfonamido-substituted hydroxamic acids
US5863949A (en) 1995-03-08 1999-01-26 Pfizer Inc Arylsulfonylamino hydroxamic acid derivatives
KR20000068248A (ko) 1996-08-23 2000-11-25 디. 제이. 우드, 스피겔 알렌 제이 아릴설포닐아미노 하이드록삼산 유도체
US6303636B1 (en) 1997-02-03 2001-10-16 Pfizer Inc Arylsulfonylamino hydroxamic acid derivatives
CA2299355C (en) 1997-08-08 2005-09-27 Pfizer Products Inc. Aryloxyarylsulfonylamino hydroxamic acid derivatives
PT895988E (pt) 1997-08-08 2002-09-30 Pfizer Prod Inc Derivados do acido arilsulfonilamino-hidroxamico
PA8469401A1 (es) 1998-04-10 2000-05-24 Pfizer Prod Inc Derivados biciclicos del acido hidroxamico

Also Published As

Publication number Publication date
KR19990083051A (ko) 1999-11-25
AU747629B2 (en) 2002-05-16
BR9901089A (pt) 2000-05-30
AP9901503A0 (en) 1999-06-30
IL129328A0 (en) 2000-02-17
EP0949244A2 (en) 1999-10-13
UA57750C2 (uk) 2003-07-15
HUP9901041A3 (en) 2003-02-28
EG22263A (en) 2002-11-30
PA8469301A1 (es) 2000-09-29
AU2369099A (en) 1999-10-21
AR018180A1 (es) 2001-10-31
TW448147B (en) 2001-08-01
KR100329902B1 (ko) 2002-03-22
SG125880A1 (en) 2006-10-30
EA002777B1 (ru) 2002-08-29
OA11031A (en) 2002-02-07
TNSN99052A1 (fr) 2005-11-10
EP0949244A3 (en) 2001-05-30
CO5070713A1 (es) 2001-08-28
YU18199A (sh) 2002-11-15
US6288246B1 (en) 2001-09-11
NZ335104A (en) 2000-10-27
BG64154B1 (bg) 2004-02-27
TR199900755A3 (tr) 1999-11-22
ID23337A (id) 2000-04-05
MA24831A1 (fr) 1999-12-31
PE20000418A1 (es) 2000-05-23
CN1232023A (zh) 1999-10-20
BG103319A (en) 2001-08-31
NO991672L (no) 1999-10-11
HUP9901041A2 (hu) 2000-03-28
EA199900284A2 (ru) 1999-10-28
UY25460A1 (es) 1999-11-17
NO991672D0 (no) 1999-04-09
AP1203A (en) 2003-09-05
PL332450A1 (en) 1999-10-11
JPH11343277A (ja) 1999-12-14
EA199900284A3 (ru) 2000-04-24
ZA992631B (en) 2000-10-09
SK43699A3 (en) 2000-06-12
DZ2757A1 (fr) 2003-09-15
IN192342B (es) 2004-04-10
IS5019A (is) 1999-10-11
TR199900755A2 (xx) 1999-11-22
HU9901041D0 (en) 1999-06-28
HRP990105A2 (en) 2000-02-29
CA2268680A1 (en) 1999-10-10

Similar Documents

Publication Publication Date Title
IN2014CN02050A (es)
SG170116A1 (en) Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
AR036196A1 (es) Agentes de contraste multimericos dirigidos a base de peptidos
PE20061427A1 (es) Metodos para identificar objetivos terapeuticos para el tratamiento de la atrofia vulvovaginal
IL182716A (en) Method for purifying recombinant fsh
BRPI0814971A8 (pt) Proteína
GB0031527D0 (en) New use
AR026063A1 (es) Metodo para la preparacion de 5-carboxiftalida.
GT199900046A (es) Procedimiento para la preparaciòn deacidos hidroxàmicos.
CU22953A3 (es) Procedimiento para la preparación de ácidos 8-metoxiquinoloncarboxílicos
ZA200109838B (en) Substituted arylmalonic acid dinitriles as intermediates for the preparation of herbicides.
AR033029A1 (es) Metodos para recuperar acidos grasos
PL350917A1 (en) C16 unsaturated fp-selective prostaglandins analogs
WO2003064452A3 (en) Method for the preparation of highly branched polypeptides
WO2010057242A3 (de) Vakzin
IL140485A0 (en) Method for preparing hydroxymethylthiobutyric acid
BR0304463A (pt) Processos para a produção de ésteres de ácidos carboxìlicos insaturados, e para a produção de ácidos carboxìlicos insaturados
WO1998046632A3 (de) Inhibitoren für den urokinaserezeptor
BR9712144A (pt) Novos antagonistas de nmda (d- aspartato de n-metila).
ES2183162T3 (es) Ester de oxazolidina.
SI1919856T1 (sl) Postopek za pripravo gabapentina
ES2173399T3 (es) Procedimiento para la sintesis de benzotiofenos.
UY26574A1 (es) " procedimiento para la separación enzimática de racematos de derivados de aminometil-aril-ciclohexanol".
PT1015415E (pt) Novos processos estereosselectivos para a preparacao de analogos de gabapentina
ECSP992914A (es) Procedimiento para la preparacion de acidos hidroxamicos